Lee Danner & Bass Inc Abb Vie Inc. Transaction History

Lee Danner & Bass Inc

$1.3 Billion
Q2 2024

A detailed history of Lee Danner & Bass Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Lee Danner & Bass Inc holds 17,804 shares of ABBV stock, worth $3.46 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

17,804

Previous 17,864 0.34%

Holding current value

$3.46 Million

Previous $2.77 Million 10.33%

% of portfolio

0.24%

Previous 0.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $9,287 - $10,845	-60 Reduced 0.34%	17,804 $3.05 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $98,384 - $110,803	-715 Reduced 3.85%	17,864 $2.77 Million
Q3 2023 Oct 27, 2023	BUY	$133.59 - $154.65 $88,169 - $102,069	660 Added 3.68%	18,579 $2.77 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $75,133 - $93,498	-567 Reduced 3.07%	17,919 $2.41 Million
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $73,719 - $88,408	533 Added 2.97%	18,486 $2.99 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $8,052 - $9,235	60 Added 0.34%	17,953 $2.41 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $7,706 - $9,797	-56 Reduced 0.31%	17,893 $2.74 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $15,045 - $18,667	-114 Reduced 0.63%	17,949 $2.91 Million
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $192,052 - $218,007	1,805 Added 11.1%	18,063 $1.95 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $4,092 - $4,504	40 Added 0.25%	16,258 $1.76 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $12,073 - $16,300	150 Added 0.93%	16,218 $1.74 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $332,471 - $390,212	3,870 Added 31.73%	16,068 $1.41 Million
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $32,209 - $43,101	-439 Reduced 3.47%	12,198 $1.2 Million
Q1 2020 May 04, 2020	SELL	$64.5 - $97.79 $28,380 - $43,027	-440 Reduced 3.36%	12,637 $963,000
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $6,347 - $7,942	-88 Reduced 0.67%	13,077 $1.16 Million
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $24,247 - $29,152	-385 Reduced 2.84%	13,165 $997,000
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $13,140 - $16,796	200 Added 1.5%	13,550 $985,000
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $25,919 - $30,505	-336 Reduced 2.46%	13,350 $1.08 Million
Q3 2018 Nov 06, 2018	BUY	$88.91 - $98.84 $27,117 - $30,146	305 Added 2.28%	13,686 $1.29 Million
Q2 2018 Nov 02, 2018	SELL	$89.78 - $106.23 $72,272 - $85,515	-805 Reduced 5.67%	13,381 $1.24 Million
Q2 2018 Aug 06, 2018	BUY	$89.78 - $106.23 $140,954 - $166,781	1,570 Added 12.44%	14,186 $1.31 Million
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $29,259 - $39,180	-318 Reduced 2.46%	12,616 $1.19 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $65,199 - $71,496	-728 Reduced 5.33%	12,934 $1.25 Million
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $954,290 - $1.22 Million	13,662	13,662 $1.21 Million

Others Institutions Holding ABBV

# of Institutions

3,699

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.

Account

Lee Danner & Bass Inc Abb Vie Inc. Transaction History